Kruppel like factor 4 (KLF4/EZF/GKLF) : Machine learning discoveries of 2nd order synergy in Meningiomas
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background : KLF4 is a member of the KLF family of zinc finger transcription factors, which belongs to the relatively large family of SP1-like transcription factors and has been proven necessary for both induction and maintenance of pluripotency and self-renewal. Unique mutation in KLF4 (i.e KLF4K409Q) in human meningiomas have been found to change the evolutionarily conserved DNA-binding domain of KLF4, thus altering its DNA recognition preference and resulting in a shift in downstream transcriptional activity. Meningiomas are the most common intracranial primary neoplasm in adults. Patel et al. [1] analyzed 160 tumors from all 3 World Health Organization (WHO) grades (I through III) using clinical, gene expression, and sequencing data and using unsupervised clustering analysis identified 3 molecular types (A, B, and C) that reliably predicted recurrence. Further, these groups did not directly correlate with the WHO grading system, which classifies more than half of the tumors in the most aggressive molecular type as benign. Issue : Increasing evidence point to the fact that meningioma classification and grading, that is based on histopathology does not al- ways accurately predict tumor aggressiveness and recurrence behaviour and knowledge of the underlying biology of the treatment resistant meningiomas and the impact of genetic alterations in these tumors, is lacking. At the current stage more genomic studies are required to unravel the role of other genes and their interations with other genetic factors. Resolution : In a recently published work Sinha [2], a frame work of a search engine was developed which can rank combinations of factors (genes/proteins) in a signaling pathway. Adapting this search engine to the Meningioma dataset, i present here 2nd order combinations of KLF4, some of which have been known to exist via wet lab experiments, but many are yet to be tested. The reveals combinations might help oncologists/biologists test possible hypotheses that might be the causing factors in meningioma. Further, in my limited grasp, if proven true, the combinations revealed by the search engine might pave way for development of gene based therapies aimed at resolving pathological issues related to meningiomas.